Goodwin Procter advised Envisagenics, Inc. on the deal.Envisagenics, Inc. announced a research collaboration agreement with Bristol Myers Squibb Company (NYSE: BMY). The multi-year collaboration will leverage Envisagenics’…
Envisagenics’ Research Collaboration Agreement with Bristol Myers Squibb Company
